Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Leukemia, Lymphocytic, Chronic, B-Cell × venetoclax × Clear all

Phase

Phase 2 38 Phase 3 17 Phase 1 16 Phase 1/2 12 Phase 4 1 Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Rituximab 4 Cyclophosphamide 4 pirtobrutinib 2 fludarabine 2 Chlorambucil 2 venetoclax 1 ofatumumab 1 idelalisib 1 acalabrutinib 1 Valganciclovir 1 Thiotepa 1 Sirolimus 1 Radiotherapy 1 Prednisone 1 Pneumococcal Vaccines 1 Pentostatin 1 Filgrastim 1 Everolimus 1 Biopsy, Needle 1 Bendamustine Hydrochloride 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04790045 2023-10-03

LymBIO

IRCCS San Raffaele

Phase 4 Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡